Skip to main content

Table 3 Angiographic and procedural characteristics of the study population

From: Combined value of left ventricular ejection fraction and the Model for End-Stage Liver Disease (MELD) score for predicting mortality in patients with acute coronary syndrome who were undergoing percutaneous coronary intervention

Variable

Survivors (n = 663)

Non-sruvivors (n = 183)

P-value

Vessel involvement

  

0.374

 LMCA

0(0)

1 (0.6)

 

 LAD

304 (46)

76 (42)

 

 CX

99 (15)

23 (13)

 

 RCA

209 (32)

65 (36)

 

 Others

51 (8)

19 (10)

 

Multi-vessel disease n (%)

296 (45)

110 (60)

< 0.001

Stent use n (%)

634 (96)

173 (95)

0.533

Stent length. mm

21 (18–28)

23 (18–28)

0.722

Stent diameter, mm

3.4 ± 0.6

3.5 ± 0.6

0.887

Stent type

  

0.141

 DES n (%)

67 (10)

10 (6)

 

 BMS n (%)

583 (90)

168 (94)

 

Tirofiban use n (%)

257 (39)

66 (36)

0.506

  1. LMCA left main coronary artery, LAD left anterior descending coronary artery, CX circumflex coronary artery, RCA right coronary artery, DES drug-eluting stent, BMS bare-metal stent